PMAQX
Price
$47.22
Change
+$0.78 (+1.68%)
Updated
Jan 30 closing price
Net Assets
30.05B
TMIRX
Price
$10.52
Change
+$0.18 (+1.74%)
Updated
Jan 30 closing price
Net Assets
153.24M
Ad is loading...

PMAQX vs TMIRX

Header iconPMAQX vs TMIRX Comparison
Open Charts PMAQX vs TMIRXBanner chart's image
Principal MidCap R6
Price$47.22
Change+$0.78 (+1.68%)
VolumeN/A
Net Assets30.05B
Transamerica Mid Cap Growth R
Price$10.52
Change+$0.18 (+1.74%)
VolumeN/A
Net Assets153.24M
PMAQX vs TMIRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMAQX vs. TMIRX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a StrongBuy and TMIRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30.1B vs. TMIRX (153M). PMAQX pays higher dividends than TMIRX: PMAQX (0.10) vs TMIRX (0.00). PMAQX was incepted earlier than TMIRX: PMAQX (8 years) vs TMIRX (8 years). TMIRX is a more actively managed with annual turnover of: 75.00 vs. PMAQX (10.10). PMAQX (0) and TMIRX (0) have matching initial minimum investment requirements. PMAQX (20.02) and TMIRX (19.81) have marching annual gain over last year. PMAQX return over 5 years is better than : 46.13 vs. TMIRX (-5.48).
PMAQXTMIRXPMAQX / TMIRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years8 years-
Gain YTD4.0566.26965%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets30.1B153M19,673%
Annual Yield % from dividends0.100.00-
Returns for 1 year20.0219.81101%
Returns for 3 years24.4921.93112%
Returns for 5 years46.13-5.48-841%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCT6.740.37
+5.81%
Nuvectis Pharma
ROCK62.420.69
+1.12%
Gibraltar Industries
OSBC18.830.15
+0.80%
Old Second Bancorp
SRPT114.45-1.00
-0.87%
Sarepta Therapeutics
VVPR1.06-0.05
-4.50%
VivoPower International PLC